ERBB2 and neoplasm: In mice bearing human tumor xenografts exhibiting varying HER2 expression levels, DOTA-C59-DEAVDANS-ADAPT6-GSSC and DOTA-C61-(HE)3DANS-ADAPT6-GSSC were both reportedly able to differentiate between tumors expressing low and high levels of HER2 (Lindbo et al. 2018).